Biohaven Ltd.

NYSE: BHVN · Real-Time Price · USD
15.63
1.40 (9.84%)
At close: Aug 15, 2025, 3:05 PM

Biohaven Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a 462.51M
Cost of Revenue
3.92M 3.37M 1.39M 1.39M
Gross Profit
-3.92M -3.37M -1.39M 370.85M
Operating Income
-885.11M -436.05M -567.93M -218.9M
Interest Income
21.33M 17.73M n/a n/a
Pretax Income
-845.69M -409.55M -569.84M -212.43M
Net Income
-846.42M -408.17M -570.28M -213.8M
Selling & General & Admin
89.24M 62.77M 130.86M 37.41M
Research & Development
795.87M 373.28M 437.07M 181.49M
Other Expenses
n/a -3.37M n/a n/a
Operating Expenses
885.11M 432.68M 567.93M 218.9M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a 5.87M n/a n/a
Cost & Expenses
885.11M 436.05M 567.93M 218.9M
Income Tax Expense
735K -1.38M 438K 1.37M
Shares Outstanding (Basic)
91.23M 71.2M 44.74M 35.82M
Shares Outstanding (Diluted)
91.23M 71.2M 44.74M 35.82M
EPS (Basic)
-9.28 -5.73 -12.75 -5.97
EPS (Diluted)
-9.28 -5.73 -12.75 -5.97
EBITDA
-841.76M -429.14M -566.55M -217.51M
EBIT
-845.69M -409.55M -569.84M -218.9M
Depreciation & Amortization
3.92M 6.91M 1.39M 1.39M